nafronyl has been researched along with Raynaud Disease in 5 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Testicular cancer has a favorable prognosis in the majority of patients due to the excellent susceptibility to chemotherapy with cisplatin, etoposide and bleomycin (BEP), which is commonly administered over 3-4 cycles of treatment." | 1.33 | Acral necrosis after inadequate excessive administration of bleomycin in a testicular cancer patient. ( Bolte, O; Ganser, A; Grünwald, V; Schöffski, P; Wiebe, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pope, J | 1 |
| Grünwald, V | 1 |
| Bolte, O | 1 |
| Wiebe, S | 1 |
| Ganser, A | 1 |
| Schöffski, P | 1 |
| Gaylarde, PM | 2 |
| Tan, OT | 2 |
| Sarkany, I | 2 |
| Nilsen, KH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-controlled Trial of St.John's Wort(a Natural Health Product) in the Treatment on Raynaud's Phenomenon[NCT00351117] | Phase 3 | 20 participants (Actual) | Interventional | 2007-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nafronyl and Raynaud Disease
| Article | Year |
|---|---|
Raynaud's phenomenon (primary).
Topics: Amlodipine; Diltiazem; Humans; Nafronyl; Nicardipine; Nifedipine; Raynaud Disease; Vasodilator Agent | 2003 |
1 trial available for nafronyl and Raynaud Disease
| Article | Year |
|---|---|
Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon.
Topics: Clinical Trials as Topic; Cold Temperature; Double-Blind Method; Furans; Humans; Microcirculation; N | 1979 |
3 other studies available for nafronyl and Raynaud Disease
| Article | Year |
|---|---|
Acral necrosis after inadequate excessive administration of bleomycin in a testicular cancer patient.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clonidine; Dose-Response Relationship, Drug; Drug Administr | 2005 |
Blood flow changes with naftidrofuryl in systemic sclerosis and Raynaud's phenomenon.
Topics: Adult; Aged; Body Temperature Regulation; Female; Fingers; Forearm; Furans; Humans; Leg; Male; Middl | 1980 |
Effect of naftidrofuryl oxalate (praxilene) on peripheral circulation measured by calorimetry.
Topics: Adult; Body Temperature; Calorimetry; Female; Fingers; Furans; Humans; Injections, Intravenous; Male | 1978 |